Tumorgen, Inc
TumorGen is developing a novel drug discovery platform to identify unseen therapeutic targets associated with cancer metastasis. Our patented technology is used to capture circulating metastatic cancer cell clusters The have been shown to be the primary vector for disseminating distant metastases in most solid tumor cancers. Our innovative platform can open an entirely new therapeutic target space for biopharma developing drugs directly impacting the pathways of cancer metastasis.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
5
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Tumorgen, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- DF
Darren Finlay
Co-investigator · Research & Development
EmailPhone - JK
Jeffrey K. Allen
President Founder & CEO · Other
EmailPhone - SR
Steve Robinson
COO · Other
EmailPhone
Showing 3 of 4 verified contacts
Top roles at Tumorgen, Inc
4 distinct titles indexed · top 4 shown.
- 1co-investigator
- 1coo
- 1president founder
- 1president founder & ceo
Sign up to unlock all 4 contacts at Tumorgen, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Tumorgen, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.